Gene Therapy Research Institution Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Gene Therapy Research Institution General Information

Description

Operator of a drug development company intended to carry out R&D on gene therapy technology targeting mainly neurodegenerative diseases. The company specializes in developing gene therapies for refractory diseases primarily focusing on Parkinson's disease, amyotrophic lateral sclerosis (ALS), and Alzheimer's disease, enabling patients to get therapies while suffering from refractory diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Life Innovation Center 414
  • 25-22, Tonomachi 3-chome Kawasaki-ku, Kawasaki-shi
  • Kanagawa, 210-0821
  • Japan
+81 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gene Therapy Research Institution Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 24-Jun-2020 Completed Pre-Clinical Trials
2. Later Stage VC 24-Dec-2019 Completed Pre-Clinical Trials
1. Secondary Transaction - Private 19-Feb-2016 $163K 00000 Completed Pre-Clinical Trials
To view Gene Therapy Research Institution’s complete valuation and funding history, request access »

Gene Therapy Research Institution Patents

Gene Therapy Research Institution Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210292790-A1 Method for enhancing gene expression using aav vector Pending 30-Jul-2018 0000000000
JP-WO2020026968-A1 Method of enhancing gene expression by aav vector Pending 30-Jul-2018 000000000
EP-3831949-A1 Method for enhancing gene expression by aav vector Pending 30-Jul-2018 C12N15/86

Gene Therapy Research Institution Executive Team (3)

Name Title Board Seat Contact Info
Katsuhito Asai President & Chief Executive Officer
Shunta Nojiri Chief Financial Officer & Board Member
Shin-ichi Muramatsu Ph.D Chief Revenue Officer & Board Member
To view Gene Therapy Research Institution’s complete executive team members history, request access »

Gene Therapy Research Institution Board Members (6)

Name Representing Role Since
Masako Kawase Ph.D Gene Therapy Research Institution Board Member 000 0000
Shin-ichi Muramatsu Ph.D Gene Therapy Research Institution Chief Revenue Officer & Board Member 000 0000
Shunta Nojiri Gene Therapy Research Institution Chief Financial Officer & Board Member 000 0000
Takashi Nishibori Gene Therapy Research Institution Board Member 000 0000
Toshihiko Sato MD Gene Therapy Research Institution Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Gene Therapy Research Institution Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alfresa Corporation Minority 000 0000 000000 0
Medical Incubator Japan Venture Capital Minority 000 0000 000000 0
To view Gene Therapy Research Institution’s complete investors history, request access »

Gene Therapy Research Institution Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000-0000000 02-Aug-2017 00000 0000 Biotechnology 000000000
To view Gene Therapy Research Institution’s complete investments history, request access »